Eva Mistry

University of Cincinnati · company speakers →

pharma-biotechhealthcare-services

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Basic Cardiovascular Sciences Scientific Sessions

13 July 2026 Boston, United States “ARPEGGIO - LB026. ARPEGGIO phase 2 trial of Scp776, a First-in-Class Cerebroprotective Agent in Patients Undergoing Endovascular Thrombectomy: Pre-specified Efficacy Analyses”

Topics this speaker covers

pharma-biotechhealthcare-services

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →